-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

652.O4.6 652. Multiple Myeloma: Clinical and Epidemiological: Outcomes, Choices and Predispositions

Symposia: Multiple Myeloma: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, adult, epidemiology, Clinical Practice (Health Services and Quality), Clinical Research, Plasma Cell Disorders, Diversity, Equity, and Inclusion (DEI) , Diseases, Lymphoid Malignancies, Study Population, Human
Sunday, December 10, 2023: 12:00 PM-1:30 PM
Grand Hall C (Manchester Grand Hyatt San Diego)
Moderators:
Rajshekhar Chakraborty, MD, Columbia University Irving Medical Center and Monika Engelhardt, MD,
Disclosures:
Chakraborty: Janssen: Consultancy, Honoraria; Sanofi: Consultancy, Honoraria; Adaptive Biotech: Consultancy, Honoraria; Genentech: Research Funding; AbbVie: Research Funding.
this session includes abstracts with new information on risk factors, environmental and socioeconomic factors as well as clinical relevance of patients with gammopathies. This targets a broad audience of hematologists and oncologists who are often confronted with incidental findings of gammopathies in patients with various socioeconomic backgrounds.
12:00 PM

Panagiotis Zis1,2*, Rodanthi Syrigou, MD3*, Stella Fanouraki2*, Maria Gavriatopoulou, MD, PhD3*, Despina Fotiou, MD, PhD3*, Foteini Theodorakakou, MD3*, Vasiliki Spiliopoulou, MD3*, Maria Roussou, MD3*, Ioannis Ntanasis-Stathopoulos, MD, PhD3*, Panagiotis Malandrakis, MD3*, Evangelos Eleutherakis-Papaiakovou, MD3*, Magdalini Migkou, MD, PhD3*, Evangelos Terpos, MD, PhD3, Meletios A. Dimopoulos, MD, PhD3 and Efstathios Kastritis, MD3*

1Medical School, University of Cyprus, Nicosia, Cyprus
2Second Department of Neurology, Attikon University Hospital, National and Kapodistrian University of Athens, School of Medicine, Haidari, Greece
3Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

12:15 PM

Jon Thorir Oskarsson, MSc1*, Sæmundur Rögnvaldsson, MD, PhD1,2*, Sigrun Thorsteinsdottir, MD, PhD1,3, Thorir E. Long, MD, PhD1,4*, Gudrun Asta Sigurdardottir1*, Asdis Rosa Thordardottir1*, Gauti Gislason, MSc1*, Andri Olafsson1*, Jon Kristinn Sigurdsson1*, Elias Eythorsson, MD, PhD2*, Asbjorn Jonsson, MD5*, Brynjar Vidarsson, MD2*, Pall T. Onundarson, MD2, Bjarni Agnarsson, MD2*, Robert Palmason, MD1,2,4*, Margret Sigurdardottir, MD2*, Ingunn Thorsteinsdottir, MD, PhD2*, Isleifur Olafsson, MD, PhD2*, Stephen J. Harding, PhD6, Brian GM Durie, MD7, Thorvardur Jon Love, MD, PhD1,2* and Sigurdur Y. Kristinsson, MD, PhD1,2

1Faculty of Medicine, University of Iceland, Reykjavik, Iceland
2Landspitali, The National University Hospital of Iceland, Reykjavik, Iceland
3Department of Hematology, Rigshospitalet, København, Copenhagen, Denmark
4Skane University Hospital, Lund, Sweden
5Akureyri Hospital, Akureyri, Iceland
6The Binding Site Inc., Birmingham, United Kingdom
7Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA

12:30 PM

Michael Wysota, MD1, Sarah Jacobs2*, Kith Pradhan, PhD3*, Joel Rosiene, MD4*, Charles Hall, PhD2*, George Downward5*, Yocheved Halberstam2*, Nishi Shah, MBBS, MPH6, Dean Hosgood, PhD2* and Aditi Shastri, MD7

1Montefiore Medical Center, New York, NY
2Albert Einstein College of Medicine, Bronx, NY
3Montefiore Einstein Cancer Center, Blood Cancer Institute, Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
4NYU Langone, New York, NY
5Utrecht University, Utrecht, Netherlands
6Department of Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY
7Blood Cancer Institute, Department of Oncology, Albert Einstein College of Medicine, Bronx, NY

12:45 PM

Chakra Pani Chaulagain, MD, Ludovic Saba, MD, MSc*, Kaylee Sarna, MS*, Hong Liang, PhD*, Barbara Geraldine Dominguez, MBA* and Chieh-Lin Fu, MD

Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL

1:00 PM

Cristina Perez1*, Maria Jose Larrayoz2*, Iria Vazquez2*, Irache Erdozain2*, Noemi Puig, MD, PhD3, María T Cedena4*, Catarina Maia, PhD5*, Amagoia Mañu2*, Natalia Gordillo2*, Oihane Churruca2*, Diego Alignani6*, Sarai Sarvide6*, Albert Oriol Rocafiguera, MD7*, Laura Rosiñol, MD, PhD8*, Rafael Ríos, MD, PhD9*, Marta Sonia Gonzalez Perez10*, Ana Pilar Gonzalez-Rodriguez11*, Felipe De Arriba, MD, PhD12*, Jose Maria Moraleda, MD, PhD13*, Jesus Martin Sanchez14*, Luis Palomera, MD, PhD15*, Valentin Cabanas Perianes, MD16*, Maria Jose Calasanz, PhD6*, Joaquin Martinez-Lopez, MD, PhD17*, Maria Victoria Mateos, MD, PhD3, Joan Bladé, MD, PhD18*, Juan Jose Lahuerta Palacios19*, Jesus San-Miguel, MD, PhD2 and Bruno Paiva6*

1Cancer Center Clinica Universidad de Navarra, Cima Universidad de Navarra, Pamplona, Spain, Barañain, Spain
2Cancer Center Clinica Universidad de Navarra, Cima Universidad de Navarra, Pamplona, Spain, Pamplona, Spain
3Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain
4University Hospital 12 de octubre, Madrid, Spain
5Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain
6Cancer Center Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBER-ONC number CB16/12/00369 and CB16/12/00489, Pamplona, Spain
7Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain
8Hematopoietic Cell Transplantation Unit,, Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain
9Hospital Universitario Virgen De Las Nieves, Granada, ESP
10University Hospital of Santiago de Compostela, Santiago de Compostela, Spain
11Hospital Universitario Central de Asturias, Oviedo, Spain
12Hospital Morales Meseguer, IMIB-Arrixaca, Universidad de Murcia, Murcia, Spain
13Hospital Clínico Universitario Virgen de la Arrixaca. IMIB-Pascual Parrilla. University of Murcia, Murcia, Spain
14Complejo Hospitalario Regional Virgen del Rocio, Sevilla, Sevilla, ESP
15Hospital Clinico Universitario Lozano Blesa, Instituto Investigacion Sanitaria Aragon, Zaragoza, Spain
16Department of Hematology, IMIB-Virgen de la Arrixaca University Hospital. University of Murcia., Murcia, Spain
17Hospital 12 de Octubre, Madrid, Spain
18Hematology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain
19Hospital Universitario 12 de Octubre, CIBER-ONC CB16/12/00369, CNIO, Madrid, Spain

1:15 PM

Santiago Thibaud, MD1*, William Genthe2*, Saoirse Bodnar2*, Alessandro Lagana, PhD1, Jane Houldsworth, PhD3, Ajai Chari, MD2*, Adriana C Rossi, MD, MSc1, Cesar Rodriguez, MD1*, Larysa J Sanchez, MD1, Shambavi Richard, MD1, Joshua Richter, MD4, Kenan Onel, MD, PhD5*, Sundar Jagannath, MD1, Tehilla Brander6* and Samir Parekh, MD1

1Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
2Icahn School of Medicine at Mount Sinai, New York, NY
3Pathology, Icahn School of Medicine at Mount Sinai, New York, NY
4Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
5Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY
6Icahn School of Medicine At Mount Sinai, New York, NY

*signifies non-member of ASH